OPROFEN SR 200mgTablets Price in Pakistan

View latest Price, manufacturer, formulation, and pack details of OPROFEN SR 200mgTablets.

Available Products of OPROFEN SR 200mgTablets

OPROFEN SR 200mgTablets 20's

Reg#: 055334

Description of OPROFEN SR 200mgTablets

Each film coated tablets contains:Ketoprofen…........................ 200mg

Medicine Info

Pack Size: 20's

Company: CCL Pharmaceutical Pvt. Ltd.

Price of OPROFEN SR 200mgTablets

Price: Rs. 372.42

Related Keywords

  • OPROFEN SR 200mgTablets price in Pakistan
  • OPROFEN SR 200mgTablets tablet price
  • OPROFEN SR 200mgTablets Capsule price
  • CCL Pharmaceutical Pvt. Ltd. OPROFEN SR 200mgTablets price
  • Buy OPROFEN SR 200mgTablets online
  • OPROFEN SR 200mgTablets 200mg uses
  • OPROFEN SR 200mgTablets syrup price
  • OPROFEN SR 200mgTablets pack 20's cost

OPROFEN SR 200mgTablets 30's

Reg#: 055334

Description of OPROFEN SR 200mgTablets

Each film coated tablets contains:Ketoprofen…........................ 200mg

Medicine Info

Pack Size: 30's

Company: CCL Pharmaceutical Pvt. Ltd.

Price of OPROFEN SR 200mgTablets

Price: Rs. 558.63

Related Keywords

  • OPROFEN SR 200mgTablets price in Pakistan
  • OPROFEN SR 200mgTablets tablet price
  • OPROFEN SR 200mgTablets Capsule price
  • CCL Pharmaceutical Pvt. Ltd. OPROFEN SR 200mgTablets price
  • Buy OPROFEN SR 200mgTablets online
  • OPROFEN SR 200mgTablets 200mg uses
  • OPROFEN SR 200mgTablets syrup price
  • OPROFEN SR 200mgTablets pack 30's cost

Alternatives brands of OPROFEN SR 200mgTablets

Explore alternative brands for OPROFEN SR 200mgTablets below.

View Alternatives

Explore More Medicines

OPROFEN 160mgInjection

CCL Pharmaceutical Pvt. Ltd.

MRP: Rs. 413.8074

ORINASETablets

CCL Pharmaceutical Pvt. Ltd.

MRP: Rs. 240.8641

ORINASETablets

CCL Pharmaceutical Pvt. Ltd.

MRP: Rs. 371.9911

ORINASETablets

CCL Pharmaceutical Pvt. Ltd.

MRP: Rs. 633.1093

ORINASETablets

CCL Pharmaceutical Pvt. Ltd.

MRP: Rs. 956.6142

We’d love to hear your thoughts!

Share your comment below and join the conversation ✨

Comments

No comments yet. Be the first!